The global Influenza Virus Rapid Antigen Test Kit market size was valued at USD 218 million in 2023 and is forecast to a readjusted size of USD 294 million by 2030 with a CAGR of 4.2% during review period.
The Influenza Virus Rapid Antigen Test Kit is a diagnostic tool designed for the rapid detection of influenza virus antigens in patient samples. Utilizing specific antibodies, this kit enables healthcare professionals to quickly screen for the presence of influenza virus, aiding in the timely diagnosis and management of influenza infections. This rapid antigen test kit provides a convenient and efficient method for frontline healthcare workers to identify influenza cases, facilitating prompt treatment and containment measures during flu outbreaks.
This report is a detailed and comprehensive analysis for global Influenza Virus Rapid Antigen Test Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Virus Rapid Antigen Test Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza Virus Rapid Antigen Test Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
BD
Abbott
Quidel
Roche
Actim
Denka
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene
Conventional RIDT
Digital RIDT
Hospital
POCT
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Rapid results enable timely diagnosis and treatment, improving patient outcomes.
- Increasing demand for point-of-care testing supports market growth and adoption.
Weaknesses:
- Limited sensitivity and specificity compared to molecular tests may affect reliability.
- Dependence on seasonal fluctuations in influenza incidence could impact consistent demand.
Opportunities:
- Growing awareness of influenza's impact on public health presents opportunities for market expansion.
- Technological advancements could enhance test accuracy and broaden applications beyond seasonal flu.
Threats:
- Competition from alternative testing methods, such as PCR and other molecular tests, may hinder market growth.
- Regulatory challenges and changes in healthcare policies could affect product approvals and market entry.
Political:
- Government policies promoting the use of rapid diagnostic tools in healthcare systems can drive market adoption.
- Regulatory approval processes and public health funding can influence market dynamics and product availability.
Economic:
- Economic downturns or budget cuts in healthcare sectors may limit purchasing power for diagnostic tools.
- Increasing healthcare expenditure in emerging markets presents growth opportunities for affordable testing solutions.
Social:
- Growing public awareness about influenza prevention and the importance of early diagnosis boosts demand.
- Aging populations and higher susceptibility to influenza in certain demographics increase the need for diagnostic solutions.
Technological:
- Advancements in diagnostic technology can improve the accuracy and speed of rapid antigen tests.
- Integration with digital health solutions (e.g., mobile apps for result reporting) could enhance test kit usability and market adoption.
Environmental:
- Environmental regulations related to the disposal of medical waste may affect manufacturing and operational costs.
- Sustainable product development and eco-friendly packaging could appeal to environmentally-conscious consumers.
Legal:
- Strict regulations around the approval and distribution of diagnostic devices can impact market entry and expansion.
- Legal requirements for accurate labeling and reporting of test results are essential to ensure product reliability and safety.
Suppliers:
- Manufacturers of raw materials (e.g., antibodies, reagents) for test kit production.
- Regulatory bodies ensuring quality and safety standards for test kits.
Inputs:
- Raw materials required for test kit production, such as chemicals and diagnostic components.
- Technological innovations for improving test accuracy and speed.
Process:
- Production of rapid antigen test kits through manufacturing processes like reagent formulation and quality control.
- Distribution and marketing of test kits through healthcare providers, pharmacies, and clinics.
Outputs:
- Influenza virus rapid antigen test kits for healthcare professionals and consumers.
- Reliable and quick results for influenza diagnosis, improving treatment timelines.
Customers:
- Healthcare providers (hospitals, clinics) using test kits for patient diagnosis.
- End consumers seeking rapid and convenient influenza testing options.
Threat of New Entrants:
- High regulatory requirements and costs of manufacturing could deter new companies from entering the market.
- Established brands with trusted products create barriers for new competitors seeking market share.
Bargaining Power of Suppliers:
- Limited number of suppliers for critical raw materials (e.g., antibodies, reagents) could increase production costs.
- Supplier power is moderate, as there are alternative sources for some key components in the test kits.
Bargaining Power of Buyers:
- Healthcare providers have moderate bargaining power, as they often rely on established suppliers for diagnostic tools.
- End consumers have lower bargaining power due to the need for reliable, regulated diagnostic products.
Threat of Substitutes:
- PCR and other molecular diagnostic tests pose a threat due to their higher accuracy, though they are costlier and slower.
- Other point-of-care diagnostic devices or home testing solutions could offer alternatives to rapid antigen kits.
Industry Rivalry:
- The market is competitive with several established players offering similar test kits, driving price competition.
- High demand for rapid influenza testing, especially during flu seasons, intensifies rivalry among manufacturers.
Raw Materials & Components:
- Key materials like antibodies, antigens, and reagents are sourced from specialized suppliers, impacting production costs.
- The quality and availability of these components directly influence the accuracy and reliability of the test kits.
Technology & Innovation:
- Ongoing advancements in diagnostic technologies are crucial for improving the speed and accuracy of antigen tests.
- Research and development in molecular biology and immunoassay techniques can enhance test performance and open new market opportunities.
Manufacturing & Production:
- Test kit production requires high precision in formulation, assembly, and quality control to ensure reliability.
- Manufacturing facilities must comply with regulatory standards to meet market requirements and ensure safety.
Distribution & Logistics:
- Efficient distribution networks are essential to ensure timely availability of test kits in hospitals, clinics, and pharmacies.
- Cold chain logistics or specialized storage conditions may be required for certain components, impacting costs and delivery timelines.
Healthcare Providers & End Users:
- Hospitals, clinics, and pharmacies are key distributors, utilizing the test kits for patient care and diagnosis.
- Increasing adoption of at-home testing kits for convenience and early detection is expanding the market to end consumers.
Regulatory & Compliance:
- Compliance with healthcare regulations and standards ensures market entry and wide acceptance of test kits.
- Ongoing changes in healthcare policies, such as reimbursement rates, could impact the accessibility and affordability of rapid antigen tests.
Chapter 1, to describe Influenza Virus Rapid Antigen Test Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Virus Rapid Antigen Test Kit, with price, sales quantity, revenue, and global market share of Influenza Virus Rapid Antigen Test Kit from 2019 to 2024.
Chapter 3, the Influenza Virus Rapid Antigen Test Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Virus Rapid Antigen Test Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Influenza Virus Rapid Antigen Test Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Virus Rapid Antigen Test Kit.
Chapter 14 and 15, to describe Influenza Virus Rapid Antigen Test Kit sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Conventional RIDT
1.3.3 Digital RIDT
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 POCT
1.4.4 Others
1.5 Global Influenza Virus Rapid Antigen Test Kit Market Size & Forecast
1.5.1 Global Influenza Virus Rapid Antigen Test Kit Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity (2019-2030)
1.5.3 Global Influenza Virus Rapid Antigen Test Kit Average Price (2019-2030)
2 Manufacturers Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Influenza Virus Rapid Antigen Test Kit Product and Services
2.1.4 BD Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments/Updates
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Influenza Virus Rapid Antigen Test Kit Product and Services
2.2.4 Abbott Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Recent Developments/Updates
2.3 Quidel
2.3.1 Quidel Details
2.3.2 Quidel Major Business
2.3.3 Quidel Influenza Virus Rapid Antigen Test Kit Product and Services
2.3.4 Quidel Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Quidel Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Influenza Virus Rapid Antigen Test Kit Product and Services
2.4.4 Roche Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Roche Recent Developments/Updates
2.5 Actim
2.5.1 Actim Details
2.5.2 Actim Major Business
2.5.3 Actim Influenza Virus Rapid Antigen Test Kit Product and Services
2.5.4 Actim Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Actim Recent Developments/Updates
2.6 Denka
2.6.1 Denka Details
2.6.2 Denka Major Business
2.6.3 Denka Influenza Virus Rapid Antigen Test Kit Product and Services
2.6.4 Denka Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Denka Recent Developments/Updates
2.7 Guangzhou Wondfo Biotech
2.7.1 Guangzhou Wondfo Biotech Details
2.7.2 Guangzhou Wondfo Biotech Major Business
2.7.3 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
2.7.4 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
2.8 Jiangsu Bioperfectus Technologies
2.8.1 Jiangsu Bioperfectus Technologies Details
2.8.2 Jiangsu Bioperfectus Technologies Major Business
2.8.3 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Product and Services
2.8.4 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Jiangsu Bioperfectus Technologies Recent Developments/Updates
2.9 Hangzhou Biotest Biotech
2.9.1 Hangzhou Biotest Biotech Details
2.9.2 Hangzhou Biotest Biotech Major Business
2.9.3 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
2.9.4 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hangzhou Biotest Biotech Recent Developments/Updates
2.10 Wantai BioPharm
2.10.1 Wantai BioPharm Details
2.10.2 Wantai BioPharm Major Business
2.10.3 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Product and Services
2.10.4 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Wantai BioPharm Recent Developments/Updates
2.11 Daan Gene
2.11.1 Daan Gene Details
2.11.2 Daan Gene Major Business
2.11.3 Daan Gene Influenza Virus Rapid Antigen Test Kit Product and Services
2.11.4 Daan Gene Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Daan Gene Recent Developments/Updates
3 Competitive Environment: Influenza Virus Rapid Antigen Test Kit by Manufacturer
3.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Manufacturer (2019-2024)
3.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Manufacturer (2019-2024)
3.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Influenza Virus Rapid Antigen Test Kit by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Influenza Virus Rapid Antigen Test Kit Manufacturer Market Share in 2023
3.4.3 Top 6 Influenza Virus Rapid Antigen Test Kit Manufacturer Market Share in 2023
3.5 Influenza Virus Rapid Antigen Test Kit Market: Overall Company Footprint Analysis
3.5.1 Influenza Virus Rapid Antigen Test Kit Market: Region Footprint
3.5.2 Influenza Virus Rapid Antigen Test Kit Market: Company Product Type Footprint
3.5.3 Influenza Virus Rapid Antigen Test Kit Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Influenza Virus Rapid Antigen Test Kit Market Size by Region
4.1.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2030)
4.1.2 Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2030)
4.1.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Region (2019-2030)
4.2 North America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.3 Europe Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.4 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.5 South America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.6 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
5.2 Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type (2019-2030)
5.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
6.2 Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application (2019-2030)
6.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2019-2030)
7 North America
7.1 North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
7.2 North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
7.3 North America Influenza Virus Rapid Antigen Test Kit Market Size by Country
7.3.1 North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
7.3.2 North America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
8.2 Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
8.3 Europe Influenza Virus Rapid Antigen Test Kit Market Size by Country
8.3.1 Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
8.3.2 Europe Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Market Size by Region
9.3.1 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
10.2 South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
10.3 South America Influenza Virus Rapid Antigen Test Kit Market Size by Country
10.3.1 South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
10.3.2 South America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Market Size by Country
11.3.1 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Influenza Virus Rapid Antigen Test Kit Market Drivers
12.2 Influenza Virus Rapid Antigen Test Kit Market Restraints
12.3 Influenza Virus Rapid Antigen Test Kit Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Influenza Virus Rapid Antigen Test Kit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza Virus Rapid Antigen Test Kit
13.3 Influenza Virus Rapid Antigen Test Kit Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza Virus Rapid Antigen Test Kit Typical Distributors
14.3 Influenza Virus Rapid Antigen Test Kit Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. BD Basic Information, Manufacturing Base and Competitors
Table 4. BD Major Business
Table 5. BD Influenza Virus Rapid Antigen Test Kit Product and Services
Table 6. BD Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. BD Recent Developments/Updates
Table 8. Abbott Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Major Business
Table 10. Abbott Influenza Virus Rapid Antigen Test Kit Product and Services
Table 11. Abbott Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Abbott Recent Developments/Updates
Table 13. Quidel Basic Information, Manufacturing Base and Competitors
Table 14. Quidel Major Business
Table 15. Quidel Influenza Virus Rapid Antigen Test Kit Product and Services
Table 16. Quidel Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Quidel Recent Developments/Updates
Table 18. Roche Basic Information, Manufacturing Base and Competitors
Table 19. Roche Major Business
Table 20. Roche Influenza Virus Rapid Antigen Test Kit Product and Services
Table 21. Roche Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Roche Recent Developments/Updates
Table 23. Actim Basic Information, Manufacturing Base and Competitors
Table 24. Actim Major Business
Table 25. Actim Influenza Virus Rapid Antigen Test Kit Product and Services
Table 26. Actim Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Actim Recent Developments/Updates
Table 28. Denka Basic Information, Manufacturing Base and Competitors
Table 29. Denka Major Business
Table 30. Denka Influenza Virus Rapid Antigen Test Kit Product and Services
Table 31. Denka Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Denka Recent Developments/Updates
Table 33. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Guangzhou Wondfo Biotech Major Business
Table 35. Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
Table 36. Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 38. Jiangsu Bioperfectus Technologies Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Bioperfectus Technologies Major Business
Table 40. Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Product and Services
Table 41. Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Jiangsu Bioperfectus Technologies Recent Developments/Updates
Table 43. Hangzhou Biotest Biotech Basic Information, Manufacturing Base and Competitors
Table 44. Hangzhou Biotest Biotech Major Business
Table 45. Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
Table 46. Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hangzhou Biotest Biotech Recent Developments/Updates
Table 48. Wantai BioPharm Basic Information, Manufacturing Base and Competitors
Table 49. Wantai BioPharm Major Business
Table 50. Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Product and Services
Table 51. Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Wantai BioPharm Recent Developments/Updates
Table 53. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 54. Daan Gene Major Business
Table 55. Daan Gene Influenza Virus Rapid Antigen Test Kit Product and Services
Table 56. Daan Gene Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Daan Gene Recent Developments/Updates
Table 58. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Influenza Virus Rapid Antigen Test Kit Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Influenza Virus Rapid Antigen Test Kit Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Influenza Virus Rapid Antigen Test Kit, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 62. Head Office and Influenza Virus Rapid Antigen Test Kit Production Site of Key Manufacturer
Table 63. Influenza Virus Rapid Antigen Test Kit Market: Company Product Type Footprint
Table 64. Influenza Virus Rapid Antigen Test Kit Market: Company Product Application Footprint
Table 65. Influenza Virus Rapid Antigen Test Kit New Market Entrants and Barriers to Market Entry
Table 66. Influenza Virus Rapid Antigen Test Kit Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 68. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2024) & (K Units)
Table 69. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2025-2030) & (K Units)
Table 70. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2025-2030) & (USD Million)
Table 72. Global Influenza Virus Rapid Antigen Test Kit Average Price by Region (2019-2024) & (US$/Unit)
Table 73. Global Influenza Virus Rapid Antigen Test Kit Average Price by Region (2025-2030) & (US$/Unit)
Table 74. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 75. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 76. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2019-2024) & (US$/Unit)
Table 79. Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2025-2030) & (US$/Unit)
Table 80. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2019-2024) & (US$/Unit)
Table 85. Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2025-2030) & (US$/Unit)
Table 86. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 87. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 88. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 89. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 90. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 91. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 92. North America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 93. North America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 95. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 96. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 97. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 98. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 99. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 100. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 101. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2025-2030) & (USD Million)
Table 110. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 111. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 112. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 113. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 114. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 115. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 116. South America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 123. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 124. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Influenza Virus Rapid Antigen Test Kit Raw Material
Table 127. Key Manufacturers of Influenza Virus Rapid Antigen Test Kit Raw Materials
Table 128. Influenza Virus Rapid Antigen Test Kit Typical Distributors
Table 129. Influenza Virus Rapid Antigen Test Kit Typical Customers
List of Figures
Figure 1. Influenza Virus Rapid Antigen Test Kit Picture
Figure 2. Global Influenza Virus Rapid Antigen Test Kit Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Type in 2023
Figure 4. Conventional RIDT Examples
Figure 5. Digital RIDT Examples
Figure 6. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. POCT Examples
Figure 10. Others Examples
Figure 11. Global Influenza Virus Rapid Antigen Test Kit Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Virus Rapid Antigen Test Kit Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Influenza Virus Rapid Antigen Test Kit Price (2019-2030) & (US$/Unit)
Figure 15. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Influenza Virus Rapid Antigen Test Kit by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 18. Top 3 Influenza Virus Rapid Antigen Test Kit Manufacturer (Revenue) Market Share in 2023
Figure 19. Top 6 Influenza Virus Rapid Antigen Test Kit Manufacturer (Revenue) Market Share in 2023
Figure 20. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2019-2030) & (US$/Unit)
Figure 30. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application (2019-2030)
Figure 32. Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2019-2030) & (US$/Unit)
Figure 33. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 45. France Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Region (2019-2030)
Figure 53. China Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 56. India Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 68. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 70. Egypt Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 72. South Africa Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 73. Influenza Virus Rapid Antigen Test Kit Market Drivers
Figure 74. Influenza Virus Rapid Antigen Test Kit Market Restraints
Figure 75. Influenza Virus Rapid Antigen Test Kit Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Influenza Virus Rapid Antigen Test Kit in 2023
Figure 78. Manufacturing Process Analysis of Influenza Virus Rapid Antigen Test Kit
Figure 79. Influenza Virus Rapid Antigen Test Kit Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
